The vesicular amine transporter (VAT) catalyzes transport and storage of catechol and indolamin Into subcellular organelles in a wide variety of cells. It plays a central role in neurotransmissdon and is the primary target for several pharmacological agents. One of the drugs, reserpine, binds very tightly to the transporter and remains bound even after solubilization, a finding that has proven useful for purification of the transporter from bovine adrenal medulla in a fully functional state. The sequences of 26 N-terminal amino acids and of an additional 7-amino acid internal peptide are presented. Antibodies against a synthetic peptide based on the above sequences immunoprecipitate the transporter, confirming the conclusion that the peptide sequence is derived from bovine VAT. To our knowledge, documentation ofsequences of vesicular neurotransmitter transporters has not been presented previously. In addition, the sequences obtained are highly homologous to the predicted sequence of a protein from PC12 cells that confers to Chinese hamster ovary cells resistance to 1-methyl-4-phenylpyridinium (MPP+), an agent that causes parkinsonism in model systems, confirming the hypothesis that the protein conferring resistance to MPP+ is a VAT.Termination of synaptic transmission is achieved by removal of the neurotransmitter from the synaptic cleft either by chemical degradation or by transport back into the presynaptic terminal, a process catalyzed by a plasma membrane sodium-coupled transporter. Once in the cytoplasm, the neurotransmitter is accumulated in vesicles, enabling further removal of the molecule from the synaptic cleft and protection from degradation. Thus, neurotransmitter transporters play an important role in neurotransmission and are primary targets for a wide array of pharmacological agents.Transport and storage of serotonin, dopamine, norepinephrine, epinephrine, and histamine into subcellular storage organelles in a wide variety of cells are catalyzed by the vesicular amine transporter (VAT), which exchanges intravesicular H+ for cytoplasmic biogenic amines (1, 2). The energy required for amine accumulation comes from an ATP-driven H+ pump, which acidifies the vesicle lumen (3, 4). Since transporters from the different tissues accumulate various amines with affinities that are similar and they display almost identical pharmacology, it has been proposed that either identical or closely resembling proteins catalyze biogenic amine transport in all of the tissues (5, 6).Reserpine is a competitive inhibitor of amine transport in vivo and in vitro in each of the storage organelles studied (7).Its binding has been investigated in detail in chromaffin granules from bovine adrenal medulla (8, 9) and in proteoliposomes reconstituted with purified transporter (10 (12).In this communication, we describe the sequence of 26 N-terminal amino acids of bovine adrenal VAT and of an additional 7-amino acid internal peptide as obtained from formic acid digestion of the purified protein. Antibodies against a synthe...